ReleaseWire Connect

GlobalData's clinical trial report, "Psoriatic Arthritis Global Clinical Trials Review, H2, 2012" provides data on the Psoriatic Arthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Psoriatic Arthritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Psoriatic Arthritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GBI Research, a leading business intelligence provider, has released its latest research, "Offshore Drilling Industry in Asia-Pacific to 2016 - Rising Regional Demand Leading to Deepwater Focus in China". The study, which is an offering from the company's Energy Research Group, provides an in-depth analysis of the offshore drilling market in the Asia Pacific region and highlights the various concerns, shifting trends and major players in the region. The report provides forecasts for the offshore drilling industry in the Asia Pacific region to 2016. The report also provides segmental forecasts of the offshore drilling market in the Asia Pacific region by water depth and highlights the major countries in the region. The report provides in-depth analysis of the key trends and challenges in the offshore drilling market in the region. An analysis of the competitive scenario, data on the offshore wells and drilling expenditure in the region are also provided for each of the market segments.

Online Retailers in BRIC: Market Guide to 2016 provides in-depth detail on the trends and drivers of the Online Retailers market in the BRIC countries. The report includes quantitative information (historic and forecast market values), segmented at category level.

"General Retailers in Global: Market Guide to 2016" provides in-depth detail on the trends and drivers of the General Retailers market in the Global. The report includes quantitative information (historic and forecast market values), segmented at channel level.

Global Markets Direct's pharmaceuticals report, "Bavarian Nordic A/S - Product Pipeline Review - 2012" provides data on the Bavarian Nordic A/S's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Rheumatic Disorders - Pipeline Review, H2 2012', provides an overview of the Rheumatic Disorders therapeutic pipeline. This report provides information on the therapeutic development for Rheumatic Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rheumatic Disorders. 'Rheumatic Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

BMI View: Figures for power consumption provide further evidence of an improved macroeconomic trajectory in Turkey. Though not out of the woods yet, the Turkish economy seems to have turned a corner, owing primarily to more welcoming external climate and monetary policy. This picture reinforces our view that Turkey will continue to outperform power markets in Central and Eastern Europe (CEE) and prompted us to revise our forecasts for electricity consumption, with real year-on-year (y-o-y) growth of 7.9% forecast for 2012. However, we highlight that the lack of clarity in regards to the country's future electricity mix and the high cost of credit could present pertinent risks to the country's capacity expansion plans.

Real GDP growth in France has now stuttered to a halt against an uncertain global macroeconomic backdrop. We therefore maintain our forecast for the country's real GDP to contract by 0.2% in 2012, before growing by just 0.9% in 2013. French household consumption is expected to remain extremely weak throughout the course of 2012, primarily due to concerns over employment and housing.

Global Market Direct's pharmaceuticals report, "Mayne Pharma Limited - Product Pipeline Review - 2012" provides data on the Mayne Pharma Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Key Insights And Key Risks